Ignite Creation Date:
2024-05-06 @ 6:27 PM
Last Modification Date:
2024-10-26 @ 2:49 PM
Study NCT ID:
NCT05678270
Status:
RECRUITING
Last Update Posted:
2024-02-07
First Post:
2022-12-23
Brief Title:
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
Sponsor:
Beijing InnoCare Pharma Tech Co Ltd
Organization:
Beijing InnoCare Pharma Tech Co Ltd
Organization Data
Organization:
Beijing InnoCare Pharma Tech Co Ltd
Class:
INDUSTRY
Study ID:
ICP-CL-00305
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing InnoCare Pharma Tech Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None